Thursday, October 24, 2019 8:21:03 PM
--
First the Military .. then into the Public Medical applications
--
Motif Bio Shares Jump After Signing U.S. Army-Funded Project
3:50 AM ET 10/24/19 | Dow Jones
By Sabela Ojea
Shares in Motif Bio PLC (MTFB.LN) rose 27% on Thursday after the company said that it has signed a U.S. Army-funded research project to evaluate Iclaprim, which would be used to prevent and treat wound infections on the battlefield.
The clinical-stage biopharmaceutical company said it has signed the contract with the Walter Reed Army Institute of Research through a grant from the U.S. Department of Defense.
The London-listed company added aerosol technology allows delivery of antibiotics painlessly and rapidly into skin and soft tissue with low-pressure and focused delivery.
"When a wound becomes infected, it is critical to provide safe and effective treatment as fast as possible," Chief Medical Officer David Huang said.
Shares at 0745 GMT were up 0.17 pence at 0.80 pence.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
> Dow Jones Newswires
TIME is an ILLUSION
---
TIMING is an actual ART
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM